Subtype-selective metabotropic glutamate receptor antagonists particularly useful for pain, migraine June 21, 2001
Antisense oligonucleotide reverses cognitive deficits in SAMP8 mice after i.v. administration June 21, 2001
Repligen extends phase II autism trial; biological markers/response to secretin relation reported June 20, 2001
Selective presynaptic M2 antagonist facilitates acetylcholine release, improves cognition June 18, 2001